BioGenCell, developer of a unique platform for treating microvascular disease, has completed a $16 million seed round led by private investor Marius Nacht ...Middle East

NETANYA, Israel, May 9, 2022 /PRNewswire/ -- Israeli biotechnology company, BioGenCell, founded by Dr. Yael Porat and Prof. Michael Belkin, and developer of unique technology for using stem cells from the patient's own blood to treat microvascular diseases, has completed a $16 million...

Hence then, the article about biogencell developer of a unique platform for treating microvascular disease has completed a 16 million seed round led by private investor marius nacht was published today ( Monday 09/05/2022 - 07:28 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BioGenCell, developer of a unique platform for treating microvascular disease, has completed a $16 million seed round led by private investor Marius Nacht )

Also on site :

• SOUND Healthcare Communications Launches PerspectivX™, a Revolutionary AI Platform Simulating Real-world HCP Feedback
• Iran Threatens Regional Energy Sites After South Pars Strike
• Norway’s Equinor Makes Oil Discovery Near Huge Arctic Field